Home › Products › Oncology › Leuprosun 22.5mg Injection
Leuprosun 22.5mg Injection
Salt Composition: LEUPROLIDE ACETATE
- Manufacturer: SUNLIGHT LIFESCIENCE
- Pack Size: 1 VIAL(s) OF 2ML
- Dosage Form: INJECTION
- Strength: 22.5MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Keep Leuprosun 22.5mg Injection out of sight and reach of children. Store in a cool, dry place, away from direct heat and light. Store below 25oC Do not refrigerate or freeze.
₹7266.00₹15000.00
Inclusive of all taxes
Product Introduction
Leuprosun 22.5mg Injection contains the active ingredient leuprolide acetate. It is a gonadotropin-releasing hormone (GnRH) agonist. Leuprosun 22.5mg Injection is used to treat prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that normally lines the interior of the uterus but grows outside it), and uterine fibroids (benign growths of the uterus) in women. This medicine is also used in treating central precocious puberty, a condition where a child's body begins pubertal changes at an unusually early age due to certain hormonal activity. Do not receive this injection if you are allergic to leuprolide acetate or any other ingredients, including goserelin and triptorelin, in the medicine. Before receiving this medicine, inform your doctor if you have liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to become pregnant. During treatment, existing symptoms may temporarily worsen due to increased sex steroid levels in the body. Speak with your doctor regarding any concerns. Report to your doctor if your child has a progressive brain tumour. Before starting treatment, notify your doctor about underlying medical conditions such as diabetes, seizures, heart problems with chest pain, irregular heartbeats, depression, or increased risk of bone thinning (osteoporosis). This medicine is not recommended in pregnant women, breastfeeding women, and patients with abnormal vaginal bleeding. If you are a woman of childbearing age, use non-hormonal contraceptives while taking Leuprosun 22.5mg Injection. Report to your doctor if you are a man with urinary obstruction or have had surgery to remove your testicles. Tell your doctor if you experience pressure on the spinal cord, urinary disorders, or haematuria (blood in the urine).
Uses
Prostate cancer Hormone-responsive breast cancer in perimenopausal (around menopause) women Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus) Central precocious puberty (a childâs body begins to change into an adult too soon caused by a release of certain hormones)
How it works
Leuprolide acetate in Leuprosun 22.5mg Injection decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty.
How to Use
Leuprosun 22.5mg Injection is usually administered in the arm, thigh or abdomen. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Severe rash, itching Shortness or difficulty of breath Cough with blood Pulmonary embolism Severe headache Common Altered blood sugar and cholesterol levels Injection site reactions Loss of appetite Abnormal liver function Swelling in ankle or hand Difficulty sleeping, headache Mood swings, depression Weight changes Nausea, vomiting Vaginal dryness, bleeding Loss of interest in sexual intercourse Hot flushes Bone pain, muscle weakness Breast tenderness
Expert Tips
During the treatment of breast cancer, regular checkup of every three months during the treatment with the combinations of an aromatase inhibitor. Do not receive Leuprosun 22.5mg Injection if you experience any abnormal vaginal bleeding. Consult your doctor immediately if you or your child is suffering from a headache even after treating it with pain killer, vision problems, buzzing, or ringing in the ear. If you have diabetes, ask your doctor to monitor your glucose and blood sugar levels regularly. Before starting, inform your doctor if you are still mensurating.
References
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Introduction to Endocrinology: The hypothalamic-pituitary axis, 12th edition, 2011, 112
- KD Tripathi, Essentials of Medical Pharmacology, Anterior pituitary hormones, 7th edition, 2013, 243.
- Takeda UK Limited, Electronic medicines compendium (emc), [ Revised on June 2022] [ Accessed on 12th April 2023], https://www.medicines.org.uk/emc/product/4651/smpc
- Abbott Laboratories, US Food and Drug Administration, [Issued on Feb 2016] [ Accessed on 12th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020517s036_019732s041lbl.pdf
Safety Advice
Pregnancy: unsafe It is unsafe to use Leuprosun 22.5mg Injection because it is contraindicated in pregnant women. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.
Lungs: Consult your doctor Inform your doctor if you experience any pulmonary embolism, shortness or difficulty of breath, or other underlying lung conditions before taking the Leuprosun 22.5mg Injection, Consult your doctor for more information.
Breastfeeding: unsafe Leuprosun 22.5mg Injection is contraindicated in breastfeeding women. Inform your doctor if you are breastfeeding before taking this injection.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.